SPY319.34+7.98 2.56%
DIA271.54+8.21 3.12%
IXIC9,814.08+198.27 2.06%

JMP Securities Maintains Market Outperform on PLx Pharma, Lowers Price Target to $10

JMP Securities maintains PLx Pharma (NASDAQ:PLXP) with a Market Outperform and lowers the price target from $15 to $10.

Benzinga · 05/18/2020 14:41

JMP Securities maintains PLx Pharma (NASDAQ:PLXP) with a Market Outperform and lowers the price target from $15 to $10.